Funding for collaborative discovery teams with transformational research ideas.
The scheme aims to bring benefits to patients faster by acknowledging the importance of international and interdisciplinary team approaches in accelerating the understanding and translation of discoveries.
We are seeking innovative approaches to address the critical questions that could present a paradigm shift for brain tumour research or use unexplored paths to allow for new discoveries to be made.
This funding for pre-clinical studies aims to:
Multidisciplinary teams should be formed from the most talented and promising researchers across international institutions to address the issues and utilise technological advances across fields. The creation of the multidisciplinary team should facilitate research which would not be achievable without such a collaboration.
Funding of up to £1.5million per programme over five years is available.
This funding should be allocated to cover direct costs for staff, including salaries, consumables and publication costs. Requests for capital / infrastructure will not be considered since it is expected that this will be available at the Lead Institution as well as all partner organisations. Grants will be awarded to the Principal Investigator's institution. Funding can be allocated to co-investigator institutions with agreements put in place between all partner institutions.
The closing date for submitting letters of intent has passed. Successful applicants will be invited to submit a full proposal.
28 July 2017 - Deadline for receipt of letters of intent
Early September – Biomedical SAB meeting reviews letters of intent
Mid-September 2017 - Invitation for submission of full applications
20 October 2017 - Deadline for receipt of full applications
March 2018 - Biomedical SAB meeting
April 2018- Awards announced
Future funding to be confirmed in early 2018
Please read our Terms and Conditions before applying for funding.
All applications must have input from those affected by brain tumours as early as possible, preferably during scoping of the project. We strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement.
Innovative and transformative research
Collaborative and multidisciplinary emphasis
Potential for patient benefit
Milestone and goal-driven approach
Value for money and communication plans
The Brain Tumour Charity is a member of the
Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. All applications will be considered by our Biomedical Scientific Advisory Board (SAB) alongside lay representatives of people affected by brain tumours.
If you would like to discuss your application or need any information, please contact the Research Team.
E-mail: email@example.com Phone: +44 (0) 1252 418190